eFFECTOR Therapeutics Inc. (EFTR:NASDAQ) rocketted at $0.67, a gain of 44.9%. On Wed, Jan 04, 2023, EFTR:NASDAQ touched a New 2-Week High of $0.67. From Wed, Dec 21, 2022, the stock recorded 62.50% Up Days and 44.44% Green Days
The stock spiked on Tue, Aug 09, 2022 at $1.99 with a volume of 58M+.
About eFFECTOR Therapeutics Inc. (EFTR:NASDAQ)
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer.
Top 10 Gainers:
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 154.05%
- Cryptyde Inc. (TYDE:NASDAQ), 81.35%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 70.05%
- Shift Technologies Inc. (SFT:NASDAQ), 57.5%
- Relativity Acquisition Corp. (RACY:NASDAQ), 47.65%
- eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 44.9%
- Elys Game Technology Corp. (ELYS:NASDAQ), 39.96%
- Reunion Neuroscience Inc. (REUN:NASDAQ), 39.42%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 37.72%
- Theseus Pharmaceuticals Inc. (THRX:NASDAQ), 36.28%